A Phase I/II Study of WJB001 Combination Therapy on Safety and Efficacy for Advanced Solid Tumors
A phase 1/2 trial of Carboplatin, Nedaplatin, Niraparib, Bevacizumab and Toripalimab in advanced solid tumours, run by Wigen Biomedicine Technology (Shanghai) Co., Ltd., now recruiting.
Overview
A Phase I/II Study of WJB001 Combination Therapy on Safety and Efficacy for Advanced Solid Tumors is a phase 1/2 interventional study registered as NCT06953323 by Wigen Biomedicine Technology (Shanghai) Co., Ltd., with 86 participants planned, started 2025-07-10 and due to reach its primary completion in 2029-06-30. Interventions recorded: WJB001 Capsules+Paclitaxel/Paclitaxel-albumin, WJB001 Capsules+carboplatin/Nedaplatin, WJB001 Capsules+Paclitaxel+carboplatin, WJB001 Capsules+Niraparib, WJB001 Capsules+Bevacizumab and WJB001 Capsules+JS207/JS001.
Similar pages
not linked directly; found by shared links- TrialA Study Explore WJB001 Capsules in Patients With Advanced Solid Tumors
Shares WJB001, Metastatic cancer (cancer that has spread) and the tag pipeline.
- TrialA Phase I/II Study of LM-2417 in Subjects With Advanced Solid Tumours
Shares Niraparib, Toripalimab, Carboplatin, Metastatic cancer (cancer that has spread) and the tag pipeline.
- TrialA Study of SKB518 as Monotherapy or Combination Therapy in Patients With Advanced Gynecological Malignant Tumors
Shares Bevacizumab, Carboplatin, Metastatic cancer (cancer that has spread) and the tag pipeline.
- TrialPhase Ⅰ/Ⅱ Clinical Study to Evaluate ABO2011 in Advanced Solid Tumors
Shares Toripalimab, Metastatic cancer (cancer that has spread) and the tag pipeline.
- TrialA Study of WX390 Combined With Toripalimab in Patients With Advanced Solid Tumors
Shares Toripalimab, Metastatic cancer (cancer that has spread) and the tag pipeline.
- TrialA Study to Investigate the Safety, Tolerability, Pharmacokinetics (PK), and Preliminary Anticancer Activity of GSK4524101 Alone or With Niraparib in Participants With Solid Tumors
Shares Niraparib, Metastatic cancer (cancer that has spread) and the tag pipeline.
- TrialA Clinical Trial of LBL-024 Combination Drug in Patients With Advanced Solid Tumours[Substudy 01(NSCLC)]
Shares Bevacizumab, Carboplatin, Metastatic cancer (cancer that has spread) and the tag pipeline.
- TrialA Study of LM-168 as a Single Agent or in Combination With Toripalimab in Subjects With Advanced Solid Tumours
Shares Toripalimab, Metastatic cancer (cancer that has spread) and the tag pipeline.